Welcome to our dedicated page for Skyward Specialty Insurance Group SEC filings (Ticker: SKWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reserve development tables, reinsurance treaties and segment loss ratios in Skyward Specialty Insurance Group’s (SKWD) filings can overwhelm even seasoned analysts. If you have ever searched for “Skyward Specialty Insurance Group insider trading Form 4 transactions” or wondered how to decode statutory versus GAAP numbers in the 10-K, you know the challenge.
Stock Titan solves that problem. Our AI reads every Skyward Specialty Insurance Group quarterly earnings report 10-Q filing, flags shifts in combined ratios, and produces plain-English takeaways. Need real-time alerts? The platform streams Skyward Specialty Insurance Group Form 4 insider transactions real-time minutes after they hit EDGAR. From 8-K material events explained to a proxy statement executive compensation breakdown, our AI-powered summaries turn hundreds of pages into a concise brief you can act on.
- Quickly scan a Skyward Specialty Insurance Group annual report 10-K simplified to see reserve adequacy and catastrophe exposure.
- Track Skyward Specialty Insurance Group executive stock transactions Form 4 before and after major storms.
- Get instant Skyward Specialty Insurance Group earnings report filing analysis that highlights premium growth by division.
Whether you are understanding Skyward Specialty Insurance Group SEC documents with AI for strategic underwriting insights or verifying solvency ratios, every filing type is covered with up-to-the-minute updates. Skip the technical jargon—our expert layer explains what moves loss ratios, how reinsurance affects capital, and why management’s disclosures matter. Explore Skyward Specialty Insurance Group SEC filings explained simply and make better decisions, faster.
Skyward Specialty Insurance Group (SKWD) elected Christopher Peirce as a Class III director, effective February 1, 2026. The Board intends to appoint Mr. Peirce as Chair of the Audit Committee after the filing of the Company’s Form 10-K for the fiscal year ended December 31, 2025.
The Board determined Mr. Peirce is independent under Nasdaq and Sarbanes‑Oxley rules. He will receive standard non‑employee director compensation and enter the Company’s indemnification agreement. Robert Creager, currently a director, Audit Committee Chair, and Nominating and Corporate Governance Committee member, informed the Board he will not stand for re‑election as a Class I director in 2026. The Company announced these changes via press release on November 11, 2025.
Skyward Specialty Insurance Group (SKWD) filed its Q3 2025 report, showing higher revenue and earnings. Total revenues were $382,526 thousand, up from $300,888 thousand a year ago, driven by net earned premiums of $351,797 thousand.
Net income rose to $45,901 thousand, with diluted EPS of $1.10, compared with $36,668 thousand and $0.89 last year. For the nine-month period, revenues reached $1,030,956 thousand and net income was $126,798 thousand, or $3.03 diluted EPS. Operating cash flow was $356,308 thousand for the nine months. Stockholders’ equity increased to $961,423 thousand, supported by an improvement in accumulated other comprehensive income to $9,539.
Investments totaled $2,233,788 thousand, including $1,805,218 thousand of available-for-sale fixed maturities. As of October 31, 2025, common shares outstanding were 40,487,365.
Skyward Specialty Insurance Group, Inc. furnished a press release announcing results for the quarter and fiscal period ended September 30, 2025, via a Form 8-K.
The release is attached as Exhibit 99.1 and, under General Instruction B.2, the information is furnished and not deemed filed under the Exchange Act, nor incorporated by reference except as specifically stated. The filing also includes a forward-looking statements disclaimer.
Skyward Specialty Insurance Group, Inc. agreed to acquire Apollo Group Holdings Limited for $556,000,000, buying approximately 87% of Apollo now and aiming to acquire 100% at closing. About 33% of the purchase price will be paid with common stock: the Company will issue 3,679,332 shares as consideration to certain sellers and pay the remainder in cash.
The cash portion is expected to be funded in part by a new $300 million term loan underwritten by Barclays. Completion is expected in the first quarter of 2026 but is subject to signing additional short-form agreements with minority sellers and receipt of regulatory approvals, including from the UK Prudential Regulation Authority, Lloyd's and the Bermuda Monetary Authority. If closing conditions are unmet by June 2, 2026, the majority SPAs terminate automatically.
Skyward Specialty Insurance Group reported material insurance reserves and a control weakness while maintaining regulatory capital and recent financing activity. The company held $1.8 billion of reserves for unpaid losses and loss adjustment expenses at December 31, 2024, with a significant portion as IBNR estimated by actuarial methods and subject to estimation uncertainty. The auditor communicated a valuation critical audit matter on reserve estimates and expressed an adverse opinion on internal control over financial reporting. Reinsurance recoverables included concentrations with Everest Reinsurance Co. (18.0%) and eMaxx Captives (16.8%) and reinsurance collateral totaled $337.0 million. Financing actions included a $57.0 million FHLB term loan secured by pledged securities and earlier IPO and follow-on offerings that generated approximately $62.0 million and $62.5 million net proceeds respectively. Statutory measures showed net income of $108.2 million and statutory capital and surplus of $710.6 million for 2024.
FAQ
What is the current stock price of Skyward Specialty Insurance Group (SKWD)?
What is the market cap of Skyward Specialty Insurance Group (SKWD)?
